Company / Operating Income per Share
KIORA PHARMACEUTICALS INC Operating Income per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.17
FY2025
5-year range
-$14.70 / $0.17
FY2021-FY2025
Trend
+101.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share returned to growth in FY2025 after 2 years of decline, reaching $0.17.
Based on SEC 10-K filings.
0.17 in FY2025.
Improved from $-1.48 to $0.17 over the past 4 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 101.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.17 | +101.1% |
| FY2024 | -$14.70 | -894.6% |
| FY2021 | -$1.48 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | -$0.63 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026